LRN
Stride, Inc. NYSE Listed Dec 13, 2007$82.80
-1.76%
vs $84.28
Mkt Cap $3.5B
52w Low $60.61
20.1% of range
52w High $171.17
50d MA $93.12
200d MA $94.39
P/E (TTM)
13.9x
EV/EBITDA
6.8x
P/B
2.4x
Debt/Equity
0.4x
ROE
16.9%
P/FCF
10.8x
RSI (14)
37.00
ATR (14)
$4.58
Beta
0.05
50d MA
$93.12
200d MA
$94.39
Avg Volume
840.1K
Stride, Inc., a technology-based education service company, provides proprietary and third-party online curriculum, software systems, and educational services to facilitate individualized learning for students primarily in kindergarten through 12th grade (K-12) in the United States and internationally. Its technology-based products and services enable clients to attract, enroll, educate, track progress, and support students. The company offers integrated package of systems, services, products, and professional expertise to support a virtual or blended public school; individual online courses and supplemental educational products; and products and services for the general education market focused on subjects, including math, English, science, and history for kindergarten through twelfth grade students. It also provides career learning products and services that are focused on developing skills to enter in industries, including information technology, health care, and business; and focused post-secondary career learning programs, which include skills training for software engineering, healthcare, and medical fields to adult learners under Galvanize, Tech Elevator, and MedCerts brand names, as well as provides staffing and talent development services to employers. Stride, Inc. serves public and private schools, school districts, charter boards, consumers, employers, and government agencies. The company was formerly known as K12 Inc. and changed its name to Stride, Inc. in December 2020. Stride, Inc. was founded in 2000 and is headquartered in Reston, Virginia.
11720 Plaza America · Reston, VA 20190 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | AMC | 1.92 | 2.30 | +19.8% | 92.58 | -1.7% | +2.8% | +2.1% | -4.2% | -0.9% | +1.1% | — |
| Jan 27, 2026 | AMC | 2.01 | 2.12 | +5.5% | 72.43 | +24.3% | +14.2% | +1.6% | +0.7% | +2.3% | -0.9% | — |
| Oct 28, 2025 | AMC | 1.07 | 1.52 | +42.1% | 153.53 | -44.6% | -54.4% | -4.8% | +2.0% | +5.3% | -0.9% | — |
| Aug 5, 2025 | AMC | 1.83 | 2.29 | +25.1% | 128.23 | +16.2% | +15.7% | -2.9% | +3.7% | +0.7% | +4.6% | — |
| Apr 29, 2025 | AMC | 2.09 | 2.02 | -3.3% | 142.59 | +1.7% | -0.2% | +5.9% | +5.9% | +0.7% | -1.6% | — |
| Jan 28, 2025 | AMC | 1.97 | 2.03 | +3.0% | 120.65 | +5.5% | +6.0% | +4.9% | +0.6% | +2.0% | -0.8% | — |
| Oct 22, 2024 | AMC | 0.22 | 0.94 | +327.3% | 64.49 | +31.1% | +39.1% | +2.9% | -1.2% | -0.3% | +0.1% | — |
| Aug 6, 2024 | AMC | 1.27 | 1.42 | +11.8% | 71.42 | +6.0% | +9.3% | +3.5% | +1.5% | -2.7% | +3.2% | — |
| Apr 23, 2024 | AMC | 1.43 | 1.60 | +11.9% | 58.20 | +11.1% | +8.6% | +5.0% | +1.1% | +1.3% | -1.8% | — |
| Jan 23, 2024 | AMC | 1.31 | 1.54 | +17.6% | 62.09 | +11.1% | -2.0% | -2.4% | +1.5% | +0.7% | -0.9% | — |
| Oct 24, 2023 | AMC | -0.35 | 0.11 | +131.4% | 44.50 | +13.6% | +18.0% | +1.4% | +2.3% | +1.5% | -0.5% | — |
| Aug 15, 2023 | AMC | 0.87 | 1.01 | +16.1% | 38.29 | +12.7% | +4.6% | +2.1% | -0.5% | -0.1% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16 | Barrington Research | Maintains | Outperform → Outperform | — | $94.01 | $94.51 | +0.5% | +3.1% | +1.6% | +0.5% | -0.9% | +4.0% |
| Jan 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $72.43 | $90.00 | +24.3% | +14.2% | +1.6% | +0.7% | +2.3% | -0.9% |
| Jan 28 | Barrington Research | Maintains | Outperform → Outperform | — | $72.43 | $90.00 | +24.3% | +14.2% | +1.6% | +0.7% | +2.3% | -0.9% |
| Jan 21 | Barrington Research | Maintains | Outperform → Outperform | — | $69.40 | $69.30 | -0.1% | +3.2% | +1.8% | +0.5% | -2.3% | +1.2% |
| Dec 17 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $65.82 | $65.15 | -1.0% | +0.5% | -0.5% | +0.5% | +0.2% | -1.1% |
| Nov 7 | BMO Capital | Maintains | Market Perform → Market Perform | — | $70.62 | $70.15 | -0.7% | +2.0% | -9.5% | +2.1% | -1.5% | -1.0% |
| Oct 29 | BMO Capital | Downgrade | Outperform → Market Perform | — | $153.53 | $85.02 | -44.6% | -54.4% | -4.8% | +2.0% | +5.3% | -0.9% |
| Oct 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $153.53 | $85.02 | -44.6% | -54.4% | -4.8% | +2.0% | +5.3% | -0.9% |
| Oct 29 | Barrington Research | Maintains | Outperform → Outperform | — | $153.53 | $85.02 | -44.6% | -54.4% | -4.8% | +2.0% | +5.3% | -0.9% |
| Oct 24 | Canaccord Genuity | Maintains | Buy → Buy | — | $151.94 | $152.78 | +0.6% | +0.1% | +0.3% | +0.6% | -54.4% | -4.8% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $144.07 | $143.99 | -0.1% | -1.2% | +1.6% | +2.1% | +0.5% | +1.1% |
| Aug 29 | Barrington Research | Maintains | Outperform → Outperform | — | $165.66 | $166.48 | +0.5% | -1.5% | -0.9% | -1.2% | +1.5% | -0.9% |
| Aug 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $128.23 | $149.00 | +16.2% | +15.7% | -2.9% | +3.7% | +0.7% | +4.6% |
| Jul 24 | Barrington Research | Maintains | Outperform → Outperform | — | $130.72 | $130.88 | +0.1% | -1.2% | +0.6% | -1.2% | +0.1% | +0.5% |
| Apr 30 | Barrington Research | Maintains | Outperform → Outperform | — | $142.59 | $144.98 | +1.7% | -0.2% | +5.9% | +5.9% | +0.7% | -1.6% |
| Apr 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $140.99 | $141.70 | +0.5% | -0.1% | +1.2% | -0.2% | +5.9% | +5.9% |
| Apr 17 | Barrington Research | Maintains | Outperform → Outperform | — | $135.46 | $135.53 | +0.1% | +0.3% | -2.1% | +3.7% | +1.6% | -0.4% |
| Apr 1 | BMO Capital | Maintains | Outperform → Outperform | — | $126.50 | $126.91 | +0.3% | +2.1% | +1.6% | -0.5% | -4.2% | +1.1% |
| Mar 14 | Barrington Research | Maintains | Outperform → Outperform | — | $118.39 | $119.21 | +0.7% | +2.5% | +0.5% | -1.4% | +1.0% | +1.2% |
| Mar 11 | Canaccord Genuity | Maintains | Buy → Buy | — | $120.73 | $119.00 | -1.4% | -1.0% | +0.4% | -1.4% | +2.5% | +0.5% |
| Jan 30 | BMO Capital | Maintains | Outperform → Outperform | — | $127.87 | $129.08 | +0.9% | +4.9% | +0.6% | +2.0% | -0.8% | +1.4% |
| Jan 29 | Barrington Research | Maintains | Outperform → Outperform | — | $120.65 | $127.34 | +5.5% | +6.0% | +4.9% | +0.6% | +2.0% | -0.8% |
| Jan 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $120.65 | $127.34 | +5.5% | +6.0% | +4.9% | +0.6% | +2.0% | -0.8% |
| Jan 27 | Canaccord Genuity | Maintains | Buy → Buy | — | $119.38 | $117.55 | -1.5% | -0.4% | +1.5% | +6.0% | +4.9% | +0.6% |
| Jan 17 | Barrington Research | Maintains | Outperform → Outperform | — | $112.95 | $113.80 | +0.8% | +1.1% | +2.1% | +0.8% | +1.3% | +0.3% |
| Dec 12 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $106.23 | $106.34 | +0.1% | +1.1% | -1.1% | +2.6% | -1.2% | -2.1% |
| Oct 29 | Citigroup | Maintains | Neutral → Neutral | — | $91.01 | $91.05 | +0.0% | +0.1% | +3.3% | -0.8% | +0.1% | -0.3% |
| Oct 24 | BMO Capital | Maintains | Outperform → Outperform | — | $89.71 | $90.03 | +0.4% | +2.9% | -1.2% | -0.3% | +0.1% | +3.3% |
| Aug 20 | Citigroup | Downgrade | Buy → Neutral | — | $83.77 | $83.04 | -0.9% | -4.3% | -0.3% | -0.2% | +2.2% | -0.1% |
| Aug 8 | Barrington Research | Maintains | Outperform → Outperform | — | $78.03 | $79.80 | +2.3% | +3.5% | +1.5% | -2.7% | +3.2% | +0.2% |
| Aug 8 | BMO Capital | Maintains | Outperform → Outperform | — | $78.03 | $79.80 | +2.3% | +3.5% | +1.5% | -2.7% | +3.2% | +0.2% |
| Jul 31 | Barrington Research | Maintains | Outperform → Outperform | — | $76.05 | $76.14 | +0.1% | -0.1% | -2.1% | -1.5% | -2.8% | +0.3% |
| Apr 25 | BMO Capital | Maintains | Outperform → Outperform | — | $63.23 | $63.20 | -0.0% | +5.0% | +1.1% | +1.3% | -1.8% | -0.6% |
| Apr 24 | Barrington Research | Maintains | Outperform → Outperform | — | $58.20 | $64.65 | +11.1% | +8.6% | +5.0% | +1.1% | +1.3% | -1.8% |
| Apr 17 | Barrington Research | Maintains | Outperform → Outperform | — | $57.98 | $58.17 | +0.3% | -0.7% | -0.5% | -1.3% | +2.8% | +0.2% |
| Jan 29 | Citigroup | Maintains | Buy → Buy | — | $60.25 | $60.26 | +0.0% | +0.7% | -0.9% | -0.3% | +2.2% | -1.6% |
| Jan 25 | BMO Capital | Maintains | Outperform → Outperform | — | $60.82 | $61.48 | +1.1% | -2.4% | +1.5% | +0.7% | -0.9% | -0.3% |
| Jan 24 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $62.09 | $69.00 | +11.1% | -2.0% | -2.4% | +1.5% | +0.7% | -0.9% |
| Jan 24 | Barrington Research | Maintains | Outperform → Outperform | — | $62.09 | $69.00 | +11.1% | -2.0% | -2.4% | +1.5% | +0.7% | -0.9% |
| Dec 4 | Barrington Research | Maintains | Outperform → Outperform | — | $61.09 | $61.10 | +0.0% | +0.2% | -1.5% | +0.6% | -0.9% | +0.1% |
| Nov 16 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $57.01 | $57.23 | +0.4% | +0.1% | +0.1% | +1.3% | +0.4% | +1.2% |
| Nov 16 | BMO Capital | Maintains | Outperform → Outperform | — | $57.01 | $57.23 | +0.4% | +0.1% | +0.1% | +1.3% | +0.4% | +1.2% |
| Oct 26 | BMO Capital | Maintains | Outperform → Outperform | — | $52.52 | $52.89 | +0.7% | +1.4% | +2.3% | +1.5% | -0.5% | +0.7% |
| Oct 25 | Barrington Research | Maintains | Outperform → Outperform | — | $44.50 | $50.56 | +13.6% | +18.0% | +1.4% | +2.3% | +1.5% | -0.5% |
| Oct 25 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $44.50 | $50.56 | +13.6% | +18.0% | +1.4% | +2.3% | +1.5% | -0.5% |
| Aug 16 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $38.29 | $43.17 | +12.7% | +4.6% | +2.1% | -0.5% | -0.1% | +0.0% |
| Aug 16 | BMO Capital | Maintains | Outperform → Outperform | — | $38.29 | $43.17 | +12.7% | +4.6% | +2.1% | -0.5% | -0.1% | +0.0% |
| Aug 16 | Barrington Research | Maintains | Outperform → Outperform | — | $38.29 | $43.17 | +12.7% | +4.6% | +2.1% | -0.5% | -0.1% | +0.0% |
| Apr 26 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $37.79 | $42.99 | +13.8% | +13.1% | -0.5% | +1.0% | -0.3% | -3.6% |
| Apr 14 | Barrington Research | Maintains | Outperform → Outperform | — | $38.59 | $38.57 | -0.1% | -0.7% | -0.1% | -0.6% | +0.6% | -0.7% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 3,263,140 | $212M | Added | Dec 2025 |
| 2 | Vanguard Portfolio Management Llc | 2,306,152 | $203M | New | Mar 2026 |
| 3 | Janus Henderson Group Plc | 2,277,279 | $201M | New | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 1,829,897 | $161M | New | Mar 2026 |
| 5 | Swedbank Ab | 972,874 | $86M | — | Mar 2026 |
| 6 | Voss Capital, Lp | 850,000 | $75M | Added | Mar 2026 |
| 7 | Fmr Llc | 829,940 | $73M | Added | Mar 2026 |
| 8 | Invesco Ltd. | 692,257 | $61M | Reduced | Mar 2026 |
| 9 | Victory Capital Management Inc | 656,219 | $58M | Added | Mar 2026 |
| 10 | Ubs Group Ag | 596,187 | $53M | Added | Mar 2026 |
| 11 | Bank Of America Corp /de/ | 594,168 | $52M | Added | Mar 2026 |
| 12 | Principal Financial Group Inc | 734,291 | $48M | Added | Dec 2025 |
| 13 | Northern Trust Corp | 467,478 | $41M | Added | Mar 2026 |
| 14 | Rockefeller Capital Management L.p. | 396,487 | $35M | Reduced | Mar 2026 |
| 15 | Fort Washington Investment Advisors Inc /oh/ | 354,968 | $31M | Reduced | Mar 2026 |
| 16 | Bank Of Nova Scotia | 350,000 | $31M | New | Mar 2026 |
| 17 | Jpmorgan Chase & Co | 357,890 | $30M | Added | Mar 2026 |
| 18 | Jane Street Group, Llc | 448,245 | $29M | Added | Dec 2025 |
| 19 | Systematic Financial Management Lp | 327,565 | $29M | Reduced | Mar 2026 |
| 20 | Rice Hall James & Associates, Llc | 427,783 | $28M | Added | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$3.52B
Enterprise Value
$3.44B
P/E (TTM)
13.92x
Forward P/E
11.64x
PEG Ratio
0.55x
P/B
2.41x
P/S
1.67x
P/FCF
10.75x
EV/EBITDA
6.77x
Shares Out
48.4M
Financials (TTM)
Revenue
$2.41B
Net Income
$287.9M
EBITDA
$508.4M
Free Cash Flow
$372.8M
Op Cash Flow
$432.8M
EPS Basic
$6.69
EPS Diluted
$5.95
EPS Forward
$7.11
Gross Margin
39.2%
Op Margin
15.0%
Net Margin
12.0%
Balance Sheet
Total Assets
$2.29B
Total Liab.
$814.3M
Total Equity
$1.48B
Cash
$985.3M
LT Debt
$416.3M
Book Value/Sh
$34.38
Debt/Equity
0.37x
Current Ratio
5.39
Quick Ratio
5.27
Returns & Growth
ROE
16.9%
ROA
11.3%
ROIC
13.3%
Rev Growth YoY
+17.9%
EPS Growth YoY
+39.7%
Price Returns
2W
+4.5%
1M
-4.9%
3M
+9.5%
6M
+45.4%
12M
-39.0%
Technicals
52W High
$171.17
52W Low
$60.61
50d MA
$93.12
200d MA
$94.39
RSI (14)
37.00
ATR (14)
$4.58
Beta
0.05
Avg Volume
840K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$109.50
High
$125.00
Low
$94.00
Median
$109.50
Data updated apr 25, 2026 7:53pm
· Source: financialmodelingprep.com